Wed, Aug 20, 2014, 1:04 AM EDT - U.S. Markets open in 8 hrs 26 mins

Recent

% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • gpost511 gpost511 Apr 9, 2014 4:29 PM Flag

    2015 Patent for NeuVax, 2019 Patent for Abstral

    It's true, you get what you pay for.
    What did you think Galena got for $7M plus $15M?
    Second hand cast offs.

    Is it a wonder the insiders ran for the door?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Goodness gracious!

    • The patent for the active peptide in Neuvax, E-75, expires in 2015.
      GALE has a limited method of use patent for the cherry picked subgroup in the current trial.

    • The European Patent Office has intended to grant a Pharmaceutical Use Patent for Galena Biopharma's NeuVax (nelipepimut-S). The patent covers the use of NeuVax as a vaccine for the prevention of relapse in breast cancer patients with an immunochemistry (IHC) rating of 1+ or 2+ for HER2/neu protein expression and a fluorescence in situ hybridization (FISH) rating of less than 2.0 for HER2/neu gene expression.

      The patent protection is afforded in all of the European countries and will expire in April 2028.

      "This patent expands our intellectual property protection for NeuVax in Europe, and further validates our novel, cancer immunotherapy approach to preventing the recurrence of breast cancer in women who otherwise have no treatment options," said Mark J Ahn, Ph.D., president and CEO. "NeuVax is the only drug currently in Phase 3 development for patients with early-stage, node-positive breast cancer with low-to-intermediate HER2 expression status."

    • Another LIE! NeuVax has an exclusivity patent until 2028; yes, it is true that Abstral's patent expires in 2019, but don't you think that Gale management was aware of this fact. You are such a lying schmuck. The protein E-75 is up for patent expiration before 2028, but the drug NeuVax is 2028 ... get your facts straight before you publish a bunch of garbage. Oh yeah, you guys don't care about the truth. I get absolutely sick of your lies!! Go AWAY and leave this MB. You are without any credibility gpost, LIAR!!

      Sentiment: Hold

 
GALE
2.33-0.10(-4.12%)Aug 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.